Skip to main content

MECANISMOS DE ENFERMEDAD EN EL SINDROME DE ALLAN-HERNDON-DUDLEY

SAF2014-54919-R

•
Funding agency name Ministerio de Economía y Competitividad
Funding agency acronym MINECO
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos I+D+i Retos de Investigación
Call year 2014
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Management unit Secretaría de Estado de Educación, Formación Profesional y Universidades
Beneficiary centre AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 14
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Effect of Triiodothyroacetic acid treatment in Mct8 deficiency: a word of caution

  • Bárez-López, Soledad
  • Obregón, María Jesús
  • Martínez de Mena, Raquel
  • Bernal, Juan
  • Guadaño-Ferraz, Ana
  • Morte, Beatriz
[Background]: Monocarboxylate transporter 8 (MCT8) is a thyroid hormone-specific cell membrane transporter. Mutations in the MCT8 gene lead to profound psychomotor retardation and abnormal thyroid hormone serum levels with low thyroxine (T4) and high triiodothyronine (T3). Currently, therapeutic options for patients are limited. Triiodothyroacetic acid (TRIAC) has potential therapeutic value. The aim of this study was to evaluate the effects and efficacy of therapeutic doses of TRIAC on Mct8-deficient mice (Mct8KO)., [Methods]: Wild-type (Wt) and Mct8KO mice were treated with 30 ng TRIAC/g BW/day, given in drinking water, from postnatal day 21 to 30. TRIAC, T4 and T3 levels in plasma, as well as T3 and TRIAC content in the cerebral cortex and striatum were measured by specific radioimmunoassays. The activities of deiodinases 1 and 2 were measured in liver and cortex. The effect of TRIAC treatment in the expression of T3-dependent genes was measured in the heart, cerebral cortex and striatum., [Results]: Plasma TRIAC concentration were the same in Wt and Mct8KO animals after treatment. TRIAC treatment greatly decreased plasma T4 in Wt and Mct8KO mice, and reduced T3 to normal levels in the Mct8KO. Deiodinase 1 activity and gene expression in the liver increased while it did not have any effect on the expression of Serca2a in the heart. TRIAC treatment did not induce the expression of T3-dependent genes in the cerebral cortex or striatum but further decreased expression of Flywch2 in the cortex and Aldh1a1 and Flywch2 in the striatum. Direct measurements of TRIAC and T3 content in the cortex and striatum revealed a decrease in T3 after treatment with no significant increase in the level of endogenous TRIAC., [Conclusions]: Therapeutic doses of TRIAC in Mct8KO mice restored plasma T3 levels but severely decreased T4 levels. TRIAC has a direct effect on deiodinase 1 in the liver and does not have an effect on gene expression in the heart. The increase in the plasma TRIAC levels after treatment is not sufficient to increase TRIAC levels in the brain and to promote the expression of T3-dependent genes in brain cells. Instead, it leads to a state of brain hypothyroidism with reduced T3 content., This work was supported by Grants from the Mehuer Foundation and the Seville's College of Pharmacists, Ramón Areces Foundation (CIVP16A1805), Spanish Ministry of Economy and Competitiveness (SAF2011-25608, SAF2014-54919-R, SAF 2012-32491) and S2010/BMD-2423 from CAM and under the frame of E‑Rare‑2 and the “Centro de Investigación Biomédica en Red de Enfermedades Raras, Instituto de Salud Carlos III” under the frame of the ERA-Net for Research on Rare Diseases. S.B.-L. is recipient of a predoctoral fellowship and contract from the FPI program of the Plan Nacional de I+D+i. The cost of this publication has been paid in part by FEDER funds., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Thyroid hormone regulated genes in cerebral cortex development

  • Bernal, Juan
The physiological and developmental effects of thyroid hormones are mainly due to the control of gene expression after interaction of T with the nuclear receptors. To understand the role of thyroid hormones on cerebral cortex development, knowledge of the genes regulated by T during specific stages of development is required. In our laboratory, we previously identified genes regulated by T in primary cerebrocortical cells in culture. By comparing these data with transcriptomics of purified cell types from the developing cortex, the cellular targets of T can be identified. In addition, many of the genes regulated transcriptionally by T have defined roles in cortex development, from which the role of T can be derived. This review analyzes the specific roles of T-regulated genes in the different stages of cortex development within the physiological frame of the developmental changes of thyroid hormones and receptor concentrations in the human cerebral cortex during fetal development. These data indicate an increase in the sensitivity to T during the second trimester of fetal development. The main cellular targets of T appear to be the Cajal-Retzius and the subplate neurons. On the other hand, T regulates transcriptionally genes encoding extracellular matrix proteins, involved in cell migration and the control of diverse signaling pathways., Supported with grants SAF2014-54919-R from the Ministry of Economy and Competitivity and the Center for Biomedical Research on Rare Diseases (CIBERER) under the frame of E-Rare-2, the ERA-Net for Research on Rare Diseases, and by FEDER funds., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

MCT8 deficiency in male mice mitigates the phenotypic abnormalities associated with the absence of a functional type 3 deiodinase

  • Morte, Beatriz
  • Bernal, Juan
  • Hernández, Arturo
Mice deficient in the type 3 deiodinase (D3KO mice) manifest impaired clearance of thyroid hormone (TH), leading to elevated levels of TH action during development. This alteration causes reduced neonatal viability, growth retardation, and central hypothyroidism. Here we examined how these phenotypes are affected by a deficiency in the monocarboxylate transporter 8 (MCT8), which is a major contributor to the transport of the active thyroid hormone, T, into the cell. MCT8 deficiency eliminated the neonatal lethality of type 3 deiodinase (D3)-deficient mice and significantly ameliorated their growth retardation. Double-mutant newborn mice exhibited similar peripheral thyrotoxicosis and increased brain expression of T-dependent genes as mice with D3 deficiency only. Later in neonatal life and adulthood, double-mutant mice manifested central and peripheral TH status similar to mice with single MCT8 deficiency, with low serum T, elevated serum TSH and T, and decreased T-dependent gene expression in the hypothalamus. In double-mutant adult mice, both thyroid gland size and the hypothyroidism-induced rise in TSH were greater than those in mice with single D3 deficiency but less than those in mice with MCT8 deficiency alone. Our results demonstrate that the marked phenotypic abnormalities observed in the D3-deficient mouse, including perinatal mortality, growth retardation, and central hypothyroidism in adult animals, require expression of MCT8, confirming the interdependent relationship between the TH transport into cells and the deiodination processes., This work was partially supported by Grants MH083220, DK095908, and MH096050 from the National Institutes of Health; Grant CIVP16A1805 from Fundación Ramón Areces; and Grant SAF2014-54919-R from Spain’s Plan Nacional de I+D., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

The addiction-related protein ANKK1 is differentially expressed during the cell cycle in neural precursors

  • España-Serrano, Laura
  • Guerra Martín-Palacio, Noelia
  • Montero-Pedrazuela, Ana
  • Pérez-Santamarina, Estela
  • Vidal, Rebeca
  • García-Consuegra, Inés
  • Valdizán, Elsa M.
  • Pazos, Ángel
  • Palomo, Tomás
  • Jiménez-Arriero, Miguel Ángel
  • Guadaño-Ferraz, Ana
  • Hoenicka, Janet
TaqIA is a polymorphismassociated with addictions and dopamine-related traits. It is located in the ankyrin repeat and kinase domain containing 1 gene (ANKK1) nearby the gene for the dopamine D2 receptor (D2R). Since ANKK1 function is unknown, TaqIA-associated traits have been explained only by differences in D2R. Here we report ANKK1 studies in mouse and human brain using quantitative real-time PCR, Western blot, immunohistochemistry, and flow cytometry. ANKK1 mRNA and protein isoforms vary along neurodevelopment in the human and mouse brain. In mouse adult brain ANKK1 is located in astrocytes, nuclei of postmitotic neurons and neural precursors from neurogenic niches. In both embryos and adults, nuclei of neural precursors showsignificant variation of ANKK1 intensity.We demonstrate a correlation between ANKK1 and the cell cycle. Cell synchronization experiments showed a significant increment of ANKK1-kinase in mitotic cells while ANKK1-kinase overexpression affects G1 and M phase that were found to be modulated by ANKK1 alleles and apomorphine treatment. Furthermore, during embryonic neurogenesis ANKK1 was expressed in slow-dividing neuroblasts and rapidly dividing precursors which are mitotic cells. These results suggest a role of ANKK1 during the cell cycle in neural precursors thus providing biological support to brain structure involvement in the TaqIA-associated phenotypes., This work has been supported by the Instituto de Salud Carlos III grants PI11/0731 and PI15/01013 (J.H.), by Ministry of Economy and Competitiveness grants SAF2014-54919-R (A.G.-F.) and SAF2011-25020 (A.P.)., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Tesis doctoral (DoctoralThesis)

Thyroid hormone homeostasis in the perinatal mouse brain: implications for MCT8 transport defect

  • Bárez-López, Soledad
Memoria que presenta la licenciada en Biología Soledad Bárez López para optar al grado de Doctor Internacional por la Universidad Autónoma de Madrid, Departamento de bioquímica y realizada en el Instituto de Investigaciones Biomédicas “Alberto Sols”, CSIC‐UAM y el Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER)., [EN]: Thyroid hormones (TH) play an essential role both in the developing and the adult central nervous system (CNS). The concentrations of the genomically active hormone T3 in the brain depend on TH transport across the brain barriers, the local generation of T3 in astrocytes by type 2 deiodinase (D2), and TH degradation by type 3 deiodinase (D3). In addition, during foetal development, circulating TH concentrations derive partly from the mother. How all these factors interact during mice foetal development to ensure “brain euthyroidism” is not well known. This work has explored the sources of T3 that ensure brain euthyroidism during mice foetal development by treating euthyroid pregnant dams with T4 or T3 from embryonic day 12 (E12) to E18. The outcome of the treatment revealed that a large amount of foetal T4 during late gestation is of maternal origin and that maternal-foetal T3 transfer is tightly regulated, most probably at the placental level. Also, that T4 transport across the choroid plexus along with D2 activity at the blood-cerebrospinal fluid barrier might be key events in TH action in brain during foetal development, as conversion of T4 into T3 by D2 activity might be the only source of T3 during mouse brain development. Mutations in the gene expressing the TH monocarboxylate transporter 8 (MCT8), in humans, lead to altered circulating TH levels and a severe neurodevelopmental disorder. Due to the crucial role of this transporter, the interaction between Mct8-dependent transport and D2 activity was studied. D2 activity was found to be required to generate the brain hyperthyroidism characteristic of Mct8 deficient (Mct8KO) animals during perinatal stages of development. Besides, Mct8KO mice were used to test novel therapeutic approaches as possible treatments for MCT8 deficiency. The use of the TH analogue triiodothyroacetic acid (TRIAC) restored plasma T3 levels but severely decreased T4 levels leading to a state of brain hypothyroidism with reduced T3 content. Delivery of MCT8 by adeno-associated virus vectors proved that, for a successful gene therapy, restoration of MCT8 at the brain barriers is critical to mediate TH access to the brain of MCT8 deficient patients. Finally, intranasal delivery of TH as an alternative administration route increased TH levels in the systemic circulation, aggravating the peripheral hyperthyroidism, suggesting that is not a treatment option for MCT8 deficient patients., [ES]: Las hormonas tiroideas (HT) juegan un papel esencial en el desarrollo y función del sistema nervioso central. En el cerebro, las concentraciones de la hormona activa a nivel genómico, T3, dependen del transporte de HT a través de las barrera cerebrales, de la generación local de T3 en los astrocitos mediante la desyodasa tipo 2 (D2) y de la degradación de HT por la desyodasa tipo 3 (D3). Además, durante el desarrollo fetal las concentraciones de HT circulantes provienen en parte de la madre. Cómo interactúan todos estos factores durante el desarrollo fetal en ratón para asegurar un “eutiroidismo cerebral” no se conoce suficientemente. En este trabajo se han explorado las fuentes de T3 que posibilitan un eutiroidismo cerebral durante el desarrollo fetal del ratón mediante el tratamiento de madres gestantes con T4 o T3 desde el día embrionario 12 (E12) hasta E18. El resultado del tratamiento reveló que una gran parte de la T4 fetal durante las fases finales de la gestación es de origen materno y que la transferencia materno-fetal de T3 está estrictamente regulada, probablemente a nivel placentario. También, que el transporte de T4 a través del plexo coroideo junto con la actividad de D2 en la barrera sangre-líquido cefalorraquídeo podrían ser eventos claves en la acción de las HT en el cerebro durante el desarrollo fetal, ya que la conversión de T4 a T3 mediante la actividad de D2 podría ser la única fuente de T3 durante el desarrollo cerebral del ratón. Mutaciones en el gen que expresa el transportador de HT, transportador de monocarboxilatos 8 (MCT8), provocan alteraciones en los niveles circulantes de HT y discapacidades graves del neurodesarrollo en humanos. Debido al papel fundamental de este transportador, se estudió la interacción entre el transporte dependiente de Mct8 y la actividad de D2. Los resultados indican que la actividad de D2 es necesaria para generar el hipertiroidismo cerebral característico de los ratones deficientes de Mct8 durante etapas perinatales del desarrollo. Además, se utilizaron ratones deficientes de Mct8 para examinar nuevas aproximaciones terapéuticas como posibles tratamientos para la deficiencia de MCT8. El uso del análogo de HT ácido triyodotiroacético (TRIAC) restableció los niveles plasmáticos de T3 pero redujo drásticamente los niveles de T4 generando un estado de hipotiroidismo cerebral con bajo contenido de T3. La administración de MCT8 mediante virus adeno-asociados demostró que, para una eficaz terapia génica, es crítico reestablecer MCT8 en las barreras cerebrales para mediar el acceso de HT en el cerebro de pacientes deficientes de MCT8. Finalmente, la administración de HT por vía intranasal como vía alternativa aumentó los niveles circulantes de HT agravando el hipertiroidismo periférico lo que sugiere que no es una opción para el tratamiento de pacientes deficientes de MCT8., Esta tesis doctoral se ha realizado gracias al disfrute de una beca predoctoral con referencia BES-2012-052501 asociada al proyecto SAF2011-25608 concedida por el Ministerio de Economía y Competitividad. También gracias a la financiación de los proyectos SAF2011- 25608, SAF2014-54919-R, SAF 2012-32491 del Ministerio de Economía y Competitividad; S2010/BMD-2423 de la CAM; del Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER) y de la ayuda Santiago Grisolía concedida por la Fundación Mehuer y el Colegio de farmacéuticos de Sevilla., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Global transcriptome analysis of primary cerebrocortical cells: identification of genes regulated by triiodothyronine in specific cell types

  • Gil-Ibáñez, Pilar
  • García-García, Francisco
  • Dopazo, Joaquín
  • Bernal, Juan
  • Morte, Beatriz
Trabajo presentado al 3rd Symposium on Biomedical Research: "Advances and Perspectives in Neuroscience", celebrado en la Universidad Autónoma de Madrid el 22 de abril de 2016., Thyroid hormones, thyroxine, and triiodothyronine (T3) are crucial for cerebral cortex development acting through regulation of gene expression. To define the transcriptional program under T3 regulation, we have performed RNA-Seq of T3-treated and untreated primary mouse cerebrocortical cells. The expression of 1145 genes or 7.7% of expressed genes was changed upon T3 addition, of which 371 responded to T3 in the presence of cycloheximide indicating direct transcriptional regulation. The results were compared with available transcriptomic datasets of defined cellular types. In this way, we could identify targets of T3 within genes enriched in astrocytes and neurons, in specific layers including the subplate, and in specific neurons such as prepronociceptin, cholecystokinin, or cortistatin neurons. The subplate and the prepronociceptin neurons appear as potentially major targets of T3 action. T3 upregulates mostly genes related to cell membrane events, such as G-protein signaling, neurotransmission, and ion transport and downregulates genes involved in nuclear events associated with the M phase of cell cycle, such as chromosome organization and segregation. Remarkably, the transcriptomic changes induced by T3 sustain the transition from fetal to adult patterns of gene expression. The results allow defining in molecular terms the elusive role of thyroid hormones on neocortical development., This work was supported by the Center for Biomedical Research on Rare Diseases (CIBERER) of Instituto Carlos III under the frame of E-Rare-2, the ERA-Net for Research on Rare Diseases (project acronym THYRONERVE), and by grants from the Ministry of Economy (SAF2011-25608 and SAF2014-54919-R), and the Ramón Areces Foundation (CIVP16A1805). P.G.-I. was recipient of a Junta de Ampliación de Estudios (JAE) fellowship from the Consejo Superior de Investigaciones Científicas (CSIC). The cost of this publication has been paid in part by FEDER funds., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

The basal ganglia: a new possible therapeutic target in the Allan-Herndon-Dudley Syndrome

  • Montero-Atalaya, A.
  • López-Espíndola, Daniela
  • Rausell, Estrella
  • Guadaño-Ferraz, Ana
Resumen del póster presentado al 3rd Symposium on Biomedical Research: "Advances and Perspectives in Neuroscience", celebrado en la Universidad Autónoma de Madrid el 22 de abril de 2016., The Allan-Herndon-Dudley syndrome (AHDS) is a rare disease caused by mutations in the gene SLC16A2, which codifies for the monocarboxylate transporter 8 (MCT8), the solely cell-membrane transporter that specifically transports thyroid hormones. The altered expression of the mutated MCT8 causes peripheral hyperthyroidism and brain hypothyroidism, which is thought to be the cause of the neurological phenotype in AHDS patients that includes mental and developmental retardation, hypotonia and in most of the cases epilepsy. These clinical features start early in the infancy and develop in the adulthood to spastic tetraplegia and paroxysmal dyskinesia. The mechanisms underlying the disease are unknown so far and there is not an effective treatment. In this study, we have focused our work on the basal ganglia, as they are part of the motor voluntary movement controlling system. We have analyzed human paraffin-embedded brain sections of the basal ganglia taken from necropsies of AHDS patients and controls by immunohistochemistry for detection of MCT8, some of the characteristic markers of striatal neural populations (enkephalin and choline acetyltransferase) and other markers of synapsis (synaptophysin) or damage. We have observed an alteration of the basal ganglia circuitry based on the abnormal expression pattern of enkephalin and choline acetyltransferase in the striatum of the AHDS patients. We have also observed alterations in the synaptophysin staining in patients versus control basal ganglia. These results indicate that the basal ganglia are severely affected by mutations in MCT8 and that structural and functional alterations in this region could be the cause of some clinical features found in AHDS patients, which suggests that those areas could be considered therapeutic targets in AHDS., Supported by grants from the Spanish Ministry of Economy and Competitiveness (MINECO) SAF2014-54919-R., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Increased anxiety and fear memory in adult mice lacking type 2 deiodinase

  • Bárez-López, Soledad
  • Montero-Pedrazuela, Ana
  • Bosch-García, Daniel
  • Venero, César
  • Guadaño-Ferraz, Ana
A euthyroid state in the brain is crucial for its adequate development and function. Impairments in thyroid hormones (THs; T3 or 3,5,3'-triiodothyronine and T4 or thyroxine) levels and availability in brain can lead to neurological alterations and to psychiatric disorders, particularly mood disorders. The thyroid gland synthetizes mainly T4, which is secreted to circulating blood, however, most actions of THs are mediated by T3, the transcriptionally active form. In the brain, intracellular concentrations of T3 are modulated by the activity of type 2 (D2) and type 3 (D3) deiodinases. In the present work, we evaluated learning and memory capabilities and anxiety-like behavior at adult stages in mice lacking D2 (D2KO) and we analyzed the impact of D2-deficiency on TH content and on the expression of T3-dependent genes in the amygdala and the hippocampus. We found that D2KO mice do not present impairments in spatial learning and memory, but they display emotional alterations with increased anxiety-like behavior as well as enhanced auditory-cued fear memory and spontaneous recovery of fear memory following extinction. D2KO mice also presented reduced T3 content in the hippocampus and decreased expression of the T3-dependent gene Dio3 in the amygdala suggesting a hypothyroid status in this structure. We propose that the emotional dysfunctions found in D2KO mice can arise from the reduced T3 content in their brain, which consequently leads to alterations in gene expression with functional consequences. We found a downregulation in the gene encoding for the calcium-binding protein calretinin (Calb2) in the amygdala of D2KO mice that could affect the GABAergic transmission. The current findings in D2KO mice can provide insight into emotional disorders present in humans with DIO2 polymorphisms., This work was supported by institutional grants provided by the Spanish Ministry of Science and Innovation and Economy and Competitiveness (grant numbers BFU2007-62979, BFU2010-16498 and SAF2014-54919-R (AGF); AGL2014-56464-C3-2-R (CV). SBL and DBG were recipients of a fellowship from the Spanish FPI program. The cost of this publication has been paid in part by FEDER funds., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Thyroid hormone availability and action during brain development in rodents

  • Bárez-López, Soledad
  • Guadaño-Ferraz, Ana
Thyroid hormones (THs) play an essential role in the development of all vertebrates; in particular adequate TH content is crucial for proper neurodevelopment. TH availability and action in the brain are precisely regulated by several mechanisms, including the secretion of THs by the thyroid gland, the transport of THs to the brain and neural cells, THs activation and inactivation by the metabolic enzymes deiodinases and, in the fetus, transplacental passage of maternal THs. Although these mechanisms have been extensively studied in rats, in the last decade, models of genetically modified mice have been more frequently used to understand the role of the main proteins involved in TH signaling in health and disease. Despite this, there is little knowledge about the mechanisms underlying THs availability in the mouse brain. This mini-review article gathers information from findings in rats, and the latest findings in mice regarding the ontogeny of TH action and the sources of THs to the brain, with special focus on neurodevelopmental stages. Unraveling TH economy and action in the mouse brain may help to better understand the physiology and pathophysiology of TH signaling in brain and may contribute to addressing the neurological alterations due to hypo and hyperthyroidism and TH resistance syndromes., This work was supported by the Spanish Ministry of Economy and Competitiveness (grant number SAF2014-54919-R). SB-L is a recipient of a contract from the Sherman Foundation (grant number OTR02211)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Regulation of gene expression by thyroid hormone in primary astrocytes: Factors influencing the genomic response

  • Morte, Beatriz
  • Gil-Ibáñez, Pilar
  • Bernal, Juan
Astrocytes mediate the action of thyroid hormone in the brain on other neural cells through the production of the active hormone triiodothyronine (T3) from its precursor thyroxine. T3 has also many effects on the astrocytes in vivo and in culture, but whether these actions are directly mediated by transcriptional regulation is not clear. In this work, we have analyzed the genomic response to T3 of cultured astrocytes isolated from the postnatal mouse cerebral cortex using RNA sequencing. Cultured astrocytes express relevant genes of thyroid hormone metabolism and action encoding type 2 deiodinase (Dio2), Mct8 transporter (Slc16a2), T3 receptors (Thra1 and Thrb), and nuclear corepressor (Ncor1) and coactivator (Ncoa1). T3 changed the expression of 668 genes (4.5% of expressed genes), of which 117 were responsive to T3 in the presence of cycloheximide. The Wnt and Notch pathways were downregulated at the posttranscriptional level. Comparison with the effect of T3 on astrocyte-enriched genes in mixed cerebrocortical cultures isolated from fetal cortex revealed that the response to T3 is influenced by the degree of astrocyte maturation and that, in agreement with its physiological effects, T3 promotes the transition between the fetal and adult patterns of gene expression., This work was supported by the Center for Biomedical Research on Rare Diseases under the framework of E-Rare-2, the ERA-Net for Research on Rare Diseases (project acronym THYRONERVE); Grant SAF2014-54919-R from the Plan Nacional de I+D+I of Ministry of Economy and Competitivity of Spain; and by the European Regional Funds., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Sobetirome and its amide prodrug Sob-AM2 exert thyromimetic actions in Mct8-deficient brain

  • Bárez-López, Soledad
  • Hartley, Meredith D.
  • Grijota Martínez, María del Carmen
  • Scanlan, Thomas S.
  • Guadaño-Ferraz, Ana
[Background]: Loss of function mutations in the thyroid hormone (TH)-specific cell membrane transporter, the monocarboxylate transporter 8 (MCT8), lead to profound psychomotor retardation and abnormal TH serum levels, with low thyroxine (T4) and high triiodothyronine (T3). Several studies point to impaired TH transport across brain barriers as a crucial pathophysiological mechanism resulting in cerebral hypothyroidism. Treatment options for MCT8-deficient patients are limited and are focused on overcoming the brain barriers. The aim of this study was to evaluate the ability of the TH analog sobetirome and its prodrug Sob-AM2 to access the brain and exert thyromimetic actions in the absence of Mct8., [Methods]: Juvenile wild-type (Wt) mice and mice lacking Mct8 and deiodinase type 2 (Mct8/Dio2KO) were treated systemically with daily injections of vehicle, 1 mg of sobetirome/kg body weight/day, or 0.3 mg of SobAM2/kg body weight/day for seven days. Sobetirome content was measured using liquid chromatography–tandem mass spectrometry, and T4 and T3 levels by specific radioimmunoassays. The effect of sobetirome treatment in the expression of T3-dependent genes was measured in the heart, liver, and cerebral cortex by realtime polymerase chain reaction., [Results]: Sob-AM2 treatment in Mct8/Dio2KO animals led to 1.8-fold more sobetirome content in the brain and 2.5-fold less in plasma in comparison to the treatment with the parent drug sobetirome. Both sobetirome and Sob-AM2 treatments in Mct8/Dio2KO mice greatly decreased plasma T4 and T3 levels. Dio1 and Ucp2 gene expression was altered in the liver of Mct8/Dio2KO mice and was not affected by the treatments. In the heart, Hcn2 but not Atp2a2 expression was increased after treatment with the analogs. Interestingly, both sobetirome and Sob-AM2 treatments increased the expression of several T3-dependent genes in the brain such as Hr, Abcd2, Mme, and Flywch2 in Mct8/Dio2KO mice., [Conclusions]: Sobetirome and its amide prodrug Sob-AM2 can access the brain in the absence of Mct8 and exert thyromimetic actions modulating the expression of T3-dependent genes. At the peripheral level, the administration of these TH analogs results in the depletion of circulating T4 and T3. Therefore, sobetirome and Sob-AM2 have the potential to address the cerebral hypothyroidism and the peripheral hyperthyroidism characteristic of MCT8 deficiency., This work was supported by the Spanish Ministry of Economy Industry and Competitiveness (SAF2014-54919-R and SAF2017-86342-R to A.G.F.), the Sherman Foundation (OTR02211 to A.G.F.), and the National Institutes of Health (DK52798 to T.S.S. and 2T32DK007680-21 to M.D.H.), and the National Multiple Sclerosis Society (FG 2023A 1/2 to M.D.H.). The cost of this publication has been paid in part by FEDER funds., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Thyroid hormone economy in the perinatal mouse brain: Implications for cerebral cortex development

  • Bárez-López, Soledad
  • Obregón, María Jesús
  • Bernal, Juan
  • Guadaño-Ferraz, Ana
Thyroid hormones (THs, T4 and the transcriptionally active hormone T3) play an essential role in neurodevelopment; however, the mechanisms underlying T3 brain delivery during mice fetal development are not well known. This work has explored the sources of brain T3 during mice fetal development using biochemical, anatomical, and molecular approaches. The findings revealed that during late gestation, a large amount of fetal brain T4 is of maternal origin. Also, in the developing mouse brain, fetal T3 content is regulated through the conversion of T4 into T3 by type-2 deiodinase (D2) activity, which is present from earlier prenatal stages. Additionally, D2 activity was found to be essential to mediate expression of T3-dependent genes in the cerebral cortex, and also necessary to generate the transient cerebral cortex hyperthyroidism present in mice lacking the TH transporter Monocarboxylate transporter 8. Notably, the gene encoding for D2 (Dio2) was mainly expressed at the blood-cerebrospinal fluid barrier (BCSFB). Overall, these data signify that T4 deiodinated by D2 may be the only source of T3 during neocortical development. We therefore propose that D2 activity at the BCSFB converts the T4 transported across the choroid plexus into T3, thus supplying the brain with active hormone to maintain TH homeostasis., This work was supported by the Spanish Ministry of Economy and Competitiveness (grant numbers SAF2011-25608, SAF2012-32491, and SAF2014-54919-R), the Center for Biomedical Research on Rare Diseases (CIBERER) of Instituto de Salud Carlos III under the frame of E-Rare-2, the ERA-Net for Research on Rare Diseases (project acronym THYRONERVE) and by Comunidad de Madrid (CAM; grant number S2010/BMD-2423). S.B.-L. is a recipient of a predoctoral fellowship and contract from the FPI program of the Plan Nacional de I+D+i. The cost of this publication has been paid in part by FEDER funds., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Otros (Other)

Expression analysis of genes regulated by thyroid hormone in neural cells

  • Bernal, Juan
  • Morte, Beatriz
The actions of thyroid hormones on brain development and function are due primarily to regulation of gene expression. Identification of direct transcriptional responses requires cell culture approaches given the difficulty of in vivo studies. Here, we describe the use of primary cells in culture obtained from embryonic mouse cerebral cortex, to identify the set of genes regulated directly and indirectly by T3 using RNA-Seq., Supported by grants SAF2014-54919-R from the Plan Estatal de Investigación Científica y Técnica y de Innovación, Spain and by the Center for Research on Rare Dieseases (Ciberer) under the frame of E-Rare-2, the ERA-Net for Research on rare Diseases., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Thyroid hormone availability in the human fetal brain: novel entry pathways and role of radial glia

  • López-Espíndola, Daniela
  • García-Aldea, A.
  • Gómez de la Riva, Inés
  • Rodríguez-García, Ana Margarita
  • Salvatore, Domenico
  • Visser, Theo J.
  • Bernal, Juan
  • Guadaño-Ferraz, Ana
Thyroid hormones (TH) are crucial for brain development; their deficiency during neurodevelopment impairs neural cell differentiation and causes irreversible neurological alterations. Understanding TH action, and in particular the mechanisms regulating TH availability in the prenatal human brain is essential to design therapeutic strategies for neurological diseases due to impaired TH signaling during neurodevelopment. We aimed at the identification of cells involved in the regulation of TH availability in the human brain at fetal stages. To this end, we studied the distribution of the TH transporters monocarboxylate transporter 8 (MCT8) and organic anion-transporting polypeptide 1C1 (OATP1C1), as well as the TH-metabolizing enzymes types 2 and 3 deiodinases (DIO2 and DIO3). Paraffin-embedded human brain sections obtained from necropsies of thirteen fetuses from 14 to 38 gestational weeks were analyzed by immunohistochemistry and in situ hybridization. We found these proteins localized along radial glial cells, in brain barriers, in Cajal-Retzius cells, in migrating fibers of the brainstem and in some neurons and glial cells with particular and complex spatiotemporal patterns. Our findings point to an important role of radial glia in controlling TH delivery and metabolism and suggest two additional novel pathways for TH availability in the prenatal human brain: the outer, and the inner cerebrospinal fluid–brain barriers. Based on our data we propose a model of TH availability for neural cells in the human prenatal brain in which several cell types have the ability to autonomously control the required TH content., The IdiPAZ Biobank is supported by Instituto de Salud Carlos III, Spanish Health Ministry (Retic RD09/0076/00073) and Farmaindustria, through the Cooperation Program in Clinical and Translational Research of the Community of Madrid. We thank Drs. Soledad Bárez-López, José Miguel Cosgaya, Estrella Rausell and Ana Montero-Pedrazuela for the careful reading of the manuscript and their helpful suggestions, and Javier Pérez for his help on the artwork. This work was supported by Grants from the Spanish Plan Nacional de I+D+i (Grant numbers SAF2014-54919-R and SAF2017-86342-R to A.GF and J.B), and the Center for Biomedical Research on Rare Diseases (Ciberer), Instituto de Salud Carlos III, Madrid, Spain and the Sherman Foundation (OTR02211 to A.GF). D.LE is a recipient of a fellowship from “Fellowship Training Program for Advanced Human Capital, BECAS CHILE” from the National Commission for Scientific and Technological Research (CONICYT), Gobierno de Chile. The cost of this publication has been paid in part by FEDER funds.